Showing results (1571-1580 of 1,599) with videos related to

Sort By:
Pageof 160
Journal of Cellular Biochemistry|June 7, 2014
High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cellsAmel Dudakovic, Emily Camilleri, Scott M Riester, et al.
American Journal of Hematology|May 28, 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaTamer Othman, Paul Koller, Ni-Chun Tsai, et al.
Transplantation and Cellular Therapy|January 22, 2023
Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation InotuzumabVaibhav Agrawal, Hoda Pourhassan, Ni-Chun Tsai, et al.
Frontiers in Immunology|March 20, 2023
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational studyCorinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, et al.
Results and Problems in Cell Differentiation|July 1, 2025
Acetylation-Mediated Epigenetic Consequences for Biological Control and CancerAndrew J Fritz, Kyle T McKay, Haley W Greenyer, et al.
Neuromuscular Disorders : NMD|July 2, 2013
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal studyE Mazzone, F Bianco, M Main, et al.
Orthopaedic Journal of Sports Medicine|October 21, 2021
Application of Machine Learning Algorithms to Predict Clinically Meaningful Improvement After Arthroscopic Anterior Cruciate Ligament ReconstructionKyle N Kunze, Evan M Polce, Anil S Ranawat, et al.
Haematologica|October 4, 2017
Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational statusIbrahim Aldoss, Anh Pham, Sierra Min Li, et al.
Blood Advances|July 11, 2022
Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALLIbrahim Aldoss, Dongyun Yang, Vanina Tomasian, et al.
ESMO Open|January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer studyG Ku, G M Haag, H Park, et al.
Pageof 160